2007 Press releases

Displaying 1 - 10 of 11

19 December 2007
Clavis Pharma enters into Market Maker Agreement

The investment bank ABG Sundal Collier Norge ASA will from 20 December 2007 quote bid and ask prices in the Clavis Pharma share in ...

15 October 2007
Clavis Pharma Completes its Executive Management Team

Clavis Pharma ASA announced today the appointment of Jan Alfheim as Chief Business Officer. Mr. Alfheim has ..

20 September 2007
Clavis Pharma Receives European Orphan Drug Designation of ELACYT for the Treatment of Acute Myeloid Leukaemia

Clavis Pharma today announced that the European Commission has granted orphan drug designation to ELACYTTM for the treatment of Acute Myeloid Leukaemia ...

17 September 2007
Clavis Pharma Strengthens Senior Management

Mr. Geir Christian Melen has been appointed as the new Chief Executive Officer of Clavis Pharma. Mr. Melen will take up his new responsibilities as ...

24 August 2007
Second Quarter Report 2007

Clavis Pharma ASA continued its research and development focus during the second quarter 2007, with three cancer drug candidates in development. ..

6 July 2007
Clavis Pharma announces initiation of malignant melanoma phase II clinical study

This new phase II clinical study has recently been approved by health authorities in the Norway and Sweden and is the first clinical trial where ELACYT ...

15 June 2007
Clavis Pharma presented preliminary clinical data on ELACYT at EHA

Clavis Pharma (OSE: CLAVIS) presented an update of data from its ongoing clinical Phase I/II study with ELACYT in hematologic cancers ...

17 April 2007
Clavis Pharma presents preliminary clinical data on ELACYT™ at AACR

Clavis Pharma announced today that the company presented the first preliminary data from its clinical Phase I/II study with ELACYT ...